Understanding Functional Profiling in Cancer Treatment
What is Functional Profiling?
Functional profiling is a process that utilizes a patient’s living cancer cells to identify the most effective chemotherapy drugs in a laboratory setting. This personalized approach aims to tailor treatment specifically for each individual.
Dr. Robert Nagourney’s Contributions
Dr. Robert Nagourney, a prominent figure in cancer research based in Los Angeles, has been applying functional profiling for decades. His innovative work has assisted over 10,000 patients with challenging cancers, significantly enhancing their chances of response to treatment.
Development of Functional Profiling
Over the past 20 years, Dr. Nagourney and his team at the Nagourney Cancer Institute have refined the laboratory technique known as functional profiling. This method evaluates the responsiveness of cancer cells to a diverse range of drugs and drug combinations. They have compiled extensive data on various cancer types, including ovarian and breast cancers, to determine optimal drug selections before administration.
The Importance of Individualized Treatment
One of the key reasons functional profiling is effective is the unique nature of each cancer patient. Their responses to therapies can vary significantly from one individual to another. When treatments are administered without prior testing, physicians often depend on generalized guidelines that may not accommodate the specific characteristics of each patient’s cancer.
Functional Profiling vs. Genomic Analyses
Functional profiling is notably different from conventional tests provided by most medical centers, which typically rely on genomic analyses. These tests examine a patient’s chromosomal material for mutations and other genetic alterations that could influence drug selection. While this method may seem promising, only a small fraction of patients possess genetic changes relevant for therapeutic decisions.
Real-Time Insights from Functional Analyses
A human cancer encompasses both mutated and normal genes working together to form what is recognized as a malignant tumor. Functional analyses are unique in that they capture the tumor’s behavior in real-time, offering valuable insights that can guide drug selection and treatment strategies.
Validation of Functional Profiling
To demonstrate the effectiveness of functional profiling compared to genomic testing, Dr. Nagourney and his colleagues performed a meta-analysis involving over 2,500 cancer cases, ranging from blood-borne to solid tumors. This research led to the creation of a statistical model known as a receiver-operator curve (ROC). The findings revealed that patients receiving “good” drugs—those identified as active or sensitive in the laboratory—were 2.04 times more likely to respond positively to treatment.